Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Autoimmune Disorders

Free Subscription 18.02.2019 1 Ann Neurol 1 BMC Neurol 2 Brain 5 Diabet Med 4 Diabetes Res Clin Pract 1 J Autoimmun 1 J Clin Endocrinol Metab 1 J Immunol 1 J Neuroimmunol 3 J Neurol 2 J Pediatr 1 J Rheumatol 1 Lancet Child Adolesc Health 1 Lancet Psychiatry 3 Mult Scler 1 Neurology 1 PLoS One 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Neurol

1. DALLA COSTA G, Martinelli V, Moiola L, Sangalli F, et al
   Serum neurofilaments increase at PML onset in natalizumab-treated MS patients.
   Ann Neurol. 2019 Feb 13. doi: 10.1002/ana.25437.
   PubMed     Text format     Abstract available
   
   

   
   BMC Neurol

2. HEMOND CC, Glanz BI, Bakshi R, Chitnis T, et al
   The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis.
   BMC Neurol. 2019;19:23.
   PubMed     Text format     Abstract available
   
   

   
   Brain

3. MEXHITAJ I, Nyirenda MH, Li R, O'Mahony J, et al
   Abnormal effector and regulatory T cell subsets in paediatric-onset multiple sclerosis.
   Brain. 2019 Feb 12. pii: 5316384. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
4. KADOWAKI A, Saga R, Lin Y, Sato W, et al
   Gut microbiota-dependent CCR9+CD4+ T cells are altered in secondary progressive multiple sclerosis.
   Brain. 2019 Feb 15. pii: 5321131. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   Diabet Med

5. HANSEN CS, Theilade S, Lajer M, Hansen TW, et al
   Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes.
   Diabet Med. 2018 Jul 12. doi: 10.1111/dme.13777.
   PubMed     Text format     Abstract available
   
   
6. MALTESE G, Fountoulakis N, Drakatos P, Shah D, et al
   Elevated obstructive sleep apnoea risk score is associated with poor healing of diabetic foot ulcers: a prospective cohort study.
   Diabet Med. 2018 Jul 19. doi: 10.1111/dme.13780.
   PubMed     Text format     Abstract available
   
   
7. SAOJI N, Palta M, Young HN, Moreno MA, et al
   The relationship of Type 1 diabetes self-management barriers to child and parent quality of life: A US cross-sectional study.
   Diabet Med. 2018 Jun 14. doi: 10.1111/dme.13760.
   PubMed     Text format     Abstract available
   
   
8. SANDERS T, Elliott J, Norman P, Johnson B, et al
   Experiences of self-management among young adults with Type 1 diabetes in the context of a structured education programme: a qualitative study.
   Diabet Med. 2018 Jul 21. doi: 10.1111/dme.13784.
   PubMed     Text format     Abstract available
   
   
9. PERERA R, Oliver N, Wilmot E, Marriott C, et al
   Variations in access to and reimbursement for continuous glucose monitoring systems for people living with Type 1 diabetes across England.
   Diabet Med. 2018 Jun 22. doi: 10.1111/dme.13766.
   PubMed     Text format     Abstract available
   
   

   
   Diabetes Res Clin Pract

10. YAMAGUCHI T, Hachiya R, Watanabe-Yamamoto S, Sawano K, et al
    Hypoglycemia in type 1A diabetes can develop before insulin therapy: A retrospective cohort study.
    Diabetes Res Clin Pract. 2019;147:87-92.
    PubMed     Text format     Abstract available
    
    
11. DOVC K, Cargnelutti K, Sturm A, Selb J, et al
    Continuous glucose monitoring use and glucose variability in pre-school children with type 1 diabetes.
    Diabetes Res Clin Pract. 2019;147:76-80.
    PubMed     Text format     Abstract available
    
    
12. GAGLIARDINO JJ, Chantelot JM, Domenger C, Ilkova H, et al
    Diabetes education and health insurance: How they affect the quality of care provided to people with type 1 diabetes in Latin America. Data from the International Diabetes Mellitus Practices Study (IDMPS).
    Diabetes Res Clin Pract. 2019;147:47-54.
    PubMed     Text format     Abstract available
    
    
13. GAGLIARDINO JJ, Chantelot JM, Domenger C, Ramachandran A, et al
    Impact of diabetes education and self-management on the quality of care for people with type 1 diabetes mellitus in the Middle East (the International Diabetes Mellitus Practices Study, IDMPS).
    Diabetes Res Clin Pract. 2019;147:29-36.
    PubMed     Text format     Abstract available
    
    

    
    J Autoimmun

14. PARIENTE A, Guedon A, Alamowitch S, Thietart S, et al
    Ischemic stroke in giant-cell arteritis: French retrospective study.
    J Autoimmun. 2019 Feb 5. pii: S0896-8411(18)30735.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Endocrinol Metab

15. KAHALY GJ, Wuster C, Olivo PD, Diana T, et al
    HIGH TITERS OF THYROTROPIN RECEPTOR ANTIBODIES ARE ASSOCIATED WITH ORBITOPATHY IN PATIENTS WITH GRAVES' DISEASE.
    J Clin Endocrinol Metab. 2019 Feb 11. pii: 5310133. doi: 10.1210/jc.2018-02705.
    PubMed     Text format     Abstract available
    
    

    
    J Immunol

16. LI R, Rezk A, Ghadiri M, Luessi F, et al
    Correction: Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
    J Immunol. 2019 Feb 15. pii: jimmunol.1900114. doi: 10.4049/jimmunol.1900114.
    PubMed     Text format    
    
    

    
    J Neuroimmunol

17. COSSU D, Yokoyama K, Sakanishi T, Momotani E, et al
    Adjuvant and antigenic properties of Mycobacterium avium subsp. paratuberculosis on experimental autoimmune encephalomyelitis.
    J Neuroimmunol. 2019 Jan 23. pii: S0165-5728(18)30552.
    PubMed     Text format     Abstract available
    
    

    
    J Neurol

18. JAKIMOVSKI D, Weinstock-Guttman B, Gandhi S, Guan Y, et al
    Dietary and lifestyle factors in multiple sclerosis progression: results from a 5-year longitudinal MRI study.
    J Neurol. 2019 Feb 13. pii: 10.1007/s00415-019-09208.
    PubMed     Text format     Abstract available
    
    
19. MASSA R, Greco G, Testi M, Rastelli E, et al
    Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
    J Neurol. 2019 Feb 11. pii: 10.1007/s00415-019-09225.
    PubMed     Text format     Abstract available
    
    
20. BLATTNER MS, de Bruin GS, Bucelli RC, Day GS, et al
    Sleep disturbances are common in patients with autoimmune encephalitis.
    J Neurol. 2019 Feb 11. pii: 10.1007/s00415-019-09230.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr

21. MAAHS DM
    Guidelines to Practice: Identifying Barriers to Cardiovascular Health Management in Pediatric Type 1 Diabetes.
    J Pediatr. 2018 Mar 16. pii: S0022-3476(18)30123.
    PubMed     Text format    
    
    
22. COSTACOU T
    Low 40-year incidence of end-stage renal disease in childhood-onset diabetes.
    J Pediatr. 2018;194:265-268.
    PubMed     Text format    
    
    

    
    J Rheumatol

23. TAO JJ, Hiraki LT, Levy DM, Silverman ED, et al
    Comparison of Sensitivities of American College of Rheumatology and Systemic Lupus International Collaborating Clinics Classification Criteria in Childhood-onset Systemic Lupus Erythematosus.
    J Rheumatol. 2019 Feb 15. pii: jrheum.180337. doi: 10.3899/jrheum.180337.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Child Adolesc Health

24. ZIEGLER AG, Hoffmann GF, Hasford J, Larsson HE, et al
    Screening for asymptomatic beta-cell autoimmunity in young children.
    Lancet Child Adolesc Health. 2019 Feb 8. pii: S2352-4642(19)30028.
    PubMed     Text format    
    
    

    
    Lancet Psychiatry

25. FINKE C
    A transdiagnostic pattern of psychiatric symptoms in autoimmune encephalitis.
    Lancet Psychiatry. 2019 Feb 11. pii: S2215-0366(19)30038.
    PubMed     Text format    
    
    

    
    Mult Scler

26. JAKIMOVSKI D, Ramanathan M, Weinstock-Guttman B, Bergsland N, et al
    Higher EBV response is associated with more severe gray matter and lesion pathology in relapsing multiple sclerosis patients: A case-controlled magnetization transfer ratio study.
    Mult Scler. 2019 Feb 13:1352458519828667. doi: 10.1177/1352458519828667.
    PubMed     Text format     Abstract available
    
    
27. SOTIRCHOS ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, et al
    Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis.
    Mult Scler. 2019 Feb 11:1352458519826364. doi: 10.1177/1352458519826364.
    PubMed     Text format     Abstract available
    
    
28. CICERO CE, Patti F, Lo Fermo S, Giuliano L, et al
    Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study.
    Mult Scler. 2019 Feb 11:1352458518825394. doi: 10.1177/1352458518825394.
    PubMed     Text format    
    
    

    
    Neurology

29. BERGER T, Stuve O
    Neurofilament light chain: An important step toward a disease biomarker in multiple sclerosis.
    Neurology. 2019 Feb 8. pii: WNL.0000000000007022.
    PubMed     Text format    
    
    

    
    PLoS One

30. POPESCU DC, Huang H, Singhal NK, Shriver L, et al
    Vitamin K enhances the production of brain sulfatides during remyelination.
    PLoS One. 2018;13:e0203057.
    PubMed     Text format     Abstract available
    
    

    
    Thyroid

31. 
    Correction to: Longitudinal Characterization of Autoantibodies to the Thyrotropin Receptor (TRAb) During Alemtuzumab Therapy: Evidence that TRAb May Precede Thyroid Dysfunction by Many Years by Muller I, Willis M, Healy S, Nasser T, Loveless S, Butter
    Thyroid. 2019;29:309.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: